Israel Cañadas

9PUBLICATIONS
145CO-AUTHORS
Haematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 23, 2024
Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer.

Takahiko Murayama, Navin R Mahadevan, Catherine B Meador

|May 15, 2024
N-MYC impairs innate immune signaling in high-grade serous ovarian carcinoma.

Alex Miranda, Swetansu Pattnaik, Phineas T Hamilton

|Jan 08, 2024
Targeting DHX9 Triggers Tumor-Intrinsic Interferon Response and Replication Stress in Small Cell Lung Cancer.

Takahiko Murayama, Jun Nakayama, Xinpei Jiang

|Sep 06, 2022
MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung Cancer.

Ryohei Yoshida, Maria Saigi, Tetsuo Tani

Pageof 2